KETOBA in relation to Ketosis and RECOVERY with BDM30™ at the Arnold Summit

In relation to the novel anti-inflammatory mechanism; executed and discovered at Biologic Pharmamedical Research.

Original post: December 2, 2017

This seminar was delivered at the Arnold Summit presenting research on the bisdemethoxycurcumin discovery by Franco Cavaleri in relation to the novel anti-inflammatory mechanism; executed and discovered at Biologic Pharmamedical Research (www.biologicpharmamedical.com). 25 minutes on KETOBA pharmacology in relation to NRf2 activation, insulin resistance and ketosis; and 20 minutes on BDM pharmacology and MyoD and anti-inflammatory activity